PT-141 Dosage Guide
FDA Approved
Written by Alejandro Reyes
Founder & Lead Researcher
PN
Reviewed by Peptide Nerds Editorial · Updated April 2026
Not medical advice. Dosage information is provided for educational purposes based on published research.
Always consult a qualified healthcare provider before starting any protocol. Full disclaimer.
Dosage overview
| Typical dose | 1.75 mg per use |
| Frequency | As needed, at least 45 min before activity |
Dosing notes
FDA-approved as Vyleesi. Max 8 doses per month.
FDA-approved indications
PT-141 is FDA-approved for: Hypoactive sexual desire disorder in premenopausal women (Vyleesi).
Off-label use should only be pursued under the guidance of a licensed healthcare provider.
Important safety information
Dosage ranges listed above are based on published clinical trial protocols. Individual dosing should be determined by a qualified healthcare provider based on your specific health profile, goals, and response to treatment.
- Start at the lowest effective dose and titrate up gradually
- Monitor for side effects, especially during dose increases
- Do not exceed researched dose ranges without medical supervision
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.